You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 58 No. 12, December 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (18)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Multiple Sclerosis/ Demyelinating Disease
 •Neuropathology
 •Immunologic Disorders
 •Alert me on articles by topic

Oligoclonal Band Number as a Marker for Prognosis in Multiple Sclerosis

Jagannadha R. Avasarala, MD, PhD; Anne H. Cross, MD; John L. Trotter, MD{dagger}

Arch Neurol. 2001;58:2044-2045.

The natural course of disease in multiple sclerosis varies. Multiple sclerosis that is clinically apparent but causes minimal disability over time has been labeled benign multiple sclerosis. The ability to predict the subsequent clinical course of multiple sclerosis on the basis of clinical and other supportive data at presentation would be invaluable. In this article we report our findings based on a retrospective analysis of 1800 patients diagnosed as having multiple sclerosis, of which 44 patients met our inclusion criteria. There was a suggestion that a low or absent number of oligoclonal bands in the cerebrospinal fluid at the time of diagnosis predicts a better prognosis. However, quantification of oligoclonal bands in cerebrospinal fluid remains an insensitive prognostic indicator and must not be used to influence decisions regarding therapeutic options.


From the Department of Neurology, Washington University School of Medicine, St Louis, Mo.
{dagger}Dr Trotter died unexpectedly on July 12, 2001.


RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2001;58(12):2078-2079.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis
Thangarajh et al.
Mult Scler 2008;14:1208-1213.
ABSTRACT  

Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis
Lucchinetti et al.
Brain 2008;131:1759-1775.
ABSTRACT | FULL TEXT  

Higher IgG index found in African Americans versus Caucasians with multiple sclerosis
Rinker et al.
Neurology 2007;69:68-72.
ABSTRACT | FULL TEXT  

Elevated CSF free kappa light chains correlate with disability prognosis in multiple sclerosis.
Rinker et al.
Neurology 2006;67:1288-1290.
ABSTRACT | FULL TEXT  

Between-Laboratory Variability in Oligoclonal IgG Band Numbering
Franciotta et al.
Clin. Chem. 2005;51:270-272.
FULL TEXT  

Sample size estimates for determining treatment effects in high-risk patients with early relapsing-remitting multiple sclerosis
Scott et al.
Mult Scler 2003;9:289-292.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.